[Laparoscopic colorectal surgery].
Laparoscopic surgery have earned a firm place in the treatment of benign colon diseases. Concerning the treatment of malignant colorectal tumors the value of LAP surgery has evoked controversial assessments. On the basis of onco-surgical guidelines for colorectal carcinoma conventional standards began to sway. Independent factors like tumor stage, R0 resection, histological parameters and surgeon determine prognosis. Previous discussions about port site metastases and tumor cell dissemination by pneumoperitoneum have silenced. Several randomized studies have proven the short term superiority of LAP resection in term of postoperative pain management, bowel movement, hospital stay and rehabilitation over open methods. The late survival was as good, or better presented by some single center studies in the last five years. Newly, more multicentric randomized trials were conducted on late results of LAP surgery for malignant colorectal tumors which has been proved nonsignificantly better or equal to conventional surgery. Based on the above mentioned data laparoscopic colorectal surgery became an accepted option for treatment of colorectal carcinoma.
Kupcsulik
Péter
P
Semmelweis Egyetem AOK I. sz. Sebészeti Klinika, Budapest. kpk@seb1.sote.hu
D003108:Colonic Diseases / Q000601:surgery; D015179:Colorectal Neoplasms / Q000601:surgery; D003107:Colorectal Surgery / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D011379:Prognosis; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors